Cyclerion Therapeutics Inc

NASDAQ:CYCN  
1.76
-0.21 (-10.66%)
Earnings Announcements

Cyclerion Therapeutics Posts Quarterly Loss Of $11.3 Mln

Published: 11/09/2021 21:58 GMT
Cyclerion Therapeutics Inc (CYCN) - Cyclerion Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update.
Cyclerion Therapeutics Inc - Net Loss Was Approximately $11.3 Million for the Third Quarter of 2021.
Revenue is expected to be $0.9 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $1.15 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.